Keegan Mechels
Ophthalmology · Omaha, NENPI 1821558420
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,329 of the $3,813 with a category attached, or 61.1%. AbbVie accounts for 72.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $3,023 and has fallen 83.1% since, to $510 in 2025.
Across 22 payments — averaging $173.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Apellis Pharmaceuticals, Inc.$328
- Alcon$274
- Biotissue Holdings Inc.$181
- Genentech USA, Inc.$138
- Amgen$62
- plus $69 from 2 others
What the payments were for
- Travel & lodging$2,32961%
- Food & beverage$1,48439%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $2,762 |
| Apellis Pharmaceuticals, Inc. | 3 | $328 |
| Alcon | 3 | $274 |
| Biotissue Holdings Inc. | 2 | $181 |
| Genentech USA, Inc. | 1 | $138 |
| Amgen(2 entities) | 2 | $62 |
| Tarsus Pharmaceuticals, Inc. | 2 | $46 |
| Glaukos Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REVOLVE$2,602
- NATRELLE SALINE-FILLED BREAST IMPLANTS$2,602
- Erivedge$138
- Syfovre$125
- Clareon PanOptix Pro$121
- TRYPTYR$120
How this compares
$3,813 in reported general payments places this provider in the 85th percentile of 105 ophthalmology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 55 | $520 |
| Latanoprost | 13 | $79 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Omaha
- Brandon BaartmanOmaha$226K
- Ronald KruegerOmaha$224K
- Lorraine ProvencherOmaha$220K
- Lance KuglerOmaha$41K
- Rao ChunduryOmaha$14K
- Shane HavensOmaha$6K
- Brandon MenkeOmaha$6K
- Sao LiuOmaha$5K
- Michael HalstedOmaha$4K
- Thomas HejkalOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.